These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9480156)

  • 21. White blood cell-reduced platelet concentrates prepared by filtration using the Sepacell PL 5 II/10 II filter.
    Müller N; Knop D
    Beitr Infusionsther Transfusionsmed; 1994; 32():58-60. PubMed ID: 9422102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
    Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
    Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
    Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
    Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombocyte concentrates prepared from the buffy coat. A modified method].
    Gasová Z; Turek P
    Cas Lek Cesk; 1996 Jan; 135(3):89-91. PubMed ID: 8625376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fully automated processing of buffy-coat-derived pooled platelet concentrates.
    Janetzko K; Klüter H; van Waeg G; Eichler H
    Transfusion; 2004 Jul; 44(7):1052-8. PubMed ID: 15225247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fuji surge technique and continuous in-line filtration to improve the quality of single donor platelet concentrates.
    Moog R
    J Clin Apher; 2002; 17(4):199-203. PubMed ID: 12494413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National French observatory of the quality of blood components for transfusion.
    Chabanel A; Masse M; Begue S;
    Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates.
    Mohr H; Bayer A; Gravemann U; Müller TH
    Transfusion; 2006 Jun; 46(6):949-55. PubMed ID: 16734811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukoreduction of platelet concentrates using a 'polishing' filter.
    van der Meer PF; Pietersz RN; Reesink HW
    Vox Sang; 2000; 79(1):27-33. PubMed ID: 10971211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lymphocyte interactions in platelet concentrates from buffy coats. Determination of proliferating cells using Ki-67 antibodies].
    Müller-Steinhardt M; Klüter H; Kirchner H
    Beitr Infusionsther Transfusionsmed; 1994; 32():66-8. PubMed ID: 9480160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
    Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White cell subsets in apheresis and filtered platelet concentrates.
    Sowemimo-Coker SO; Kim A; Tribble E; Brandwein HJ; Wenz B
    Transfusion; 1998 Jul; 38(7):650-7. PubMed ID: 9683103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood transfusion preparations with a low leukocyte count. I. Preparation of thrombocyte concentrates from buffy coats].
    Gasová Z; Turek P
    Cas Lek Cesk; 1992 Dec; 131(24-25):754-5. PubMed ID: 1288879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: a retrospective analysis of count increment, corrected count increment and transfusion interval.
    Cid J; Ramiro L; Escoda L; Llorente A
    Vox Sang; 2009 Jan; 96(1):29-33. PubMed ID: 19121195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat.
    Oksanen K; Ebeling F; Kekomäki R; Elonen E; Sahlstedt L; Volin L; Myllylä G
    Vox Sang; 1994; 67(4):356-61. PubMed ID: 7701806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quality control in producing thrombocytapheresis preparations with minimal leukocyte contamination].
    Riggert J; Humpe A; Simson G; Köhler M
    Beitr Infusionsther Transfusionsmed; 1997; 34():89-94. PubMed ID: 9417356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of small volume, leuko and erythrocyte very poor platelet concentrates.
    Valbonesi M; Angelini G; Malfanti L; Lercari G; Fella M; Calderisi S; Anselmo A; Balistreri M
    Int J Artif Organs; 1986 May; 9(3):189-92. PubMed ID: 3733246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
    Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of leukodepleted platelet concentrates from pooled buffy coats: prestorage filtration with Autostop BC.
    Pietersz RN; van der Meer PF; Steneker I; Hinloopen B; Dekker WJ; van Zanten AP; Reesink HW
    Vox Sang; 1999; 76(4):231-6. PubMed ID: 10394143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.